These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| þ | ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
| o | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
| Maryland | 87-0406496 | |
| State or other jurisdiction of incorporation or organization | (I.R.S. Employer Identification No.) | |
| 9C Portland Road, West Conshohocken, PA | 19428 | |
| (Address of principal executive offices) | (Zip Code) |
| Title of each class | Name of each exchange on which registered | |
| None | Not Applicable |
| Large accelerated filer o | Accelerated filer o | Non-accelerated filer o | Smaller reporting company þ | |||
| (Do not check if a smaller reporting company) |
| Item No. | Page No. | |||||||
|
|
||||||||
|
|
||||||||
| 1 | ||||||||
|
|
||||||||
| 8 | ||||||||
|
|
||||||||
| 8 | ||||||||
|
|
||||||||
| 8 | ||||||||
|
|
||||||||
| 8 | ||||||||
|
|
||||||||
| 8 | ||||||||
|
|
||||||||
|
Part II
|
||||||||
|
|
||||||||
| 9 | ||||||||
|
|
||||||||
| 9 | ||||||||
|
|
||||||||
| 10 | ||||||||
|
|
||||||||
| 16 | ||||||||
|
|
||||||||
| 16 | ||||||||
|
|
||||||||
| 16 | ||||||||
|
|
||||||||
| 16 | ||||||||
|
|
||||||||
| 17 | ||||||||
|
|
||||||||
|
Part III
|
||||||||
|
|
||||||||
| 17 | ||||||||
|
|
||||||||
| 19 | ||||||||
|
|
||||||||
| 21 | ||||||||
|
|
||||||||
| 22 | ||||||||
|
|
||||||||
| 23 | ||||||||
|
|
||||||||
|
Part IV
|
||||||||
|
|
||||||||
| 23 | ||||||||
|
|
||||||||
| 24 | ||||||||
|
|
||||||||
| Exhibit 31.1 | ||||||||
| Exhibit 31.2 | ||||||||
| Exhibit 32.1 | ||||||||
| ITEM 1. |
BUSINESS
|
1
2
3
4
| Year Ended December 31 | ||||||||
| Product Type | 2010 | 2009 | ||||||
|
|
||||||||
|
Entertainment and Toy Technologies and Products
|
50 | % | 58 | % | ||||
|
Anti-Counterfeiting and Anti-Diversion Technologies and Products
|
47 | % | 37 | % | ||||
|
Document Security Products
|
3 | % | 5 | % | ||||
5
6
7
| ITEM 1A. |
RISK FACTORS
|
| ITEM 1B. |
UNRESOLVED STAFF COMMENTS
|
| ITEM 2. |
PROPERTIES
|
| ITEM 3. |
LEGAL PROCEEDINGS
|
| ITEM 4. |
REMOVED AND REVISED
|
8
| ITEM 5. |
MARKET FOR REGISTRANTS COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF
EQUITY SECURITIES
|
| High Bid | Low Bid | |||||||
|
January 1, 2009 to March 31, 2009
|
$ | .15 | $ | .05 | ||||
|
April 1, 2009 to June 30, 2009
|
$ | .09 | $ | .03 | ||||
|
July 1, 2009 to September 30, 2009
|
$ | .20 | $ | .04 | ||||
|
October 1, 2009 to December 31, 2009
|
$ | .16 | $ | .04 | ||||
|
|
||||||||
|
January 1, 2010 to March 31, 2010
|
$ | .10 | $ | .05 | ||||
|
April 1, 2010 to June 30, 2010
|
$ | .09 | $ | .03 | ||||
|
July 1, 2010 to September 30, 2010
|
$ | .07 | $ | .02 | ||||
|
October 1, 2010 to December 31, 2010
|
$ | .07 | $ | .01 | ||||
|
|
||||||||
|
January 1, 2011 to March 15, 2011
|
$ | .11 | $ | .04 | ||||
9
| ITEM 7. |
MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
10
11
12
13
14
15
| ITEM 7A. |
QUANTITIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
|
| ITEM 8. |
FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
|
| ITEM 9. |
CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE
|
| ITEM 9A. |
CONTROLS AND PROCEDURES
|
16
| ITEM 9B. |
OTHER INFORMATION
|
| ITEM 10. |
DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
|
17
18
| ITEM 11. |
EXECUTIVE COMPENSATION
|
| Nonqualified | ||||||||||||||||||||||||||||||||||||
| Name | Nonequity | deferred | ||||||||||||||||||||||||||||||||||
| and | Stock | Option | incentive plan | compensation | All other | |||||||||||||||||||||||||||||||
| principal | Salary | Bonus | awards | awards | compensation | earnings | compensation | Total | ||||||||||||||||||||||||||||
| position | Year | ($) | ($) | ($) | ($) | ($) | ($) | ($) | ($) | |||||||||||||||||||||||||||
| (a) | (b) | (c) | (d) | (e) | (f) | (g) | (h) | (i) | (j) | |||||||||||||||||||||||||||
|
Michael A. Feinstein, M.D.
|
||||||||||||||||||||||||||||||||||||
|
Chairman, President and Chief Executive Officer
|
2010 | 85,000 | 85,000 | |||||||||||||||||||||||||||||||||
|
|
2009 | 85,000 | 85,000 | |||||||||||||||||||||||||||||||||
19
| (a) | (b) | (c) | (d) | (e) | (f) | |||||||||||||||
| Equity | ||||||||||||||||||||
| Income | ||||||||||||||||||||
| Plan | ||||||||||||||||||||
| Number | Number | Awards | ||||||||||||||||||
| Of | Of | Number of | ||||||||||||||||||
| Securities | Securities | Securities | ||||||||||||||||||
| Underlying | Underlying | Underlying | ||||||||||||||||||
| Options | Options | Unexercised | Option | Option | ||||||||||||||||
| (#) | (#) | Options | Exercise | Expiration | ||||||||||||||||
| Name | Exercisable | Unexercisable | (#) | Price | Date | |||||||||||||||
|
|
||||||||||||||||||||
|
Michael A. Feinstein, M.D.
|
100,000 | 100,000 | $ | .215 | April 29, 2011 | |||||||||||||||
|
Michael A. Feinstein, M.D.
|
100,000 | 100,000 | $ | .45 | April 29, 2013 | |||||||||||||||
| Fees | ||||||||||||||||||||||||||||
| earned | Nonqualified | |||||||||||||||||||||||||||
| or | Nonequity | deferred | ||||||||||||||||||||||||||
| paid in | Stock | Option | incentive plan | compensation | All other | |||||||||||||||||||||||
| cash | awards | awards | compensation | earnings | compensation | Total | ||||||||||||||||||||||
| Name | ($) | ($) | ($) | ($) | ($) | ($) | ($) | |||||||||||||||||||||
| (a) | (b) | (c) | (d) | (e) | (f) | (g) | (h) | |||||||||||||||||||||
|
W. Ward Carey (1)
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||||||||||||||
|
William P. Curtis, Jr.
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||||||||||||||
|
Herman M. Gerwitz (2)
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||||||||||||||
|
Richard Levitt (3)
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||||||||||||||
|
Philip B. White (4)
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||||||||||||||
| (1) |
Mr. Carey resigned in November 2010.
|
|
| (2) |
Mr. Gerwitz held 200,000 exercisable stock options and 7,500 exercisable warrants at December 31, 2010.
|
|
| (3) |
Mr. Levitt held 200,000 exercisable stock options at December 31, 2010.
|
|
| (4) |
Mr. White held 100,000 exercisable stock options at December 31, 2010.
|
20
| ITEM 12. |
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS
|
| Common Stock | ||||||||
| Number | ||||||||
| Of Shares | ||||||||
| Beneficially | Percentage of | |||||||
| Owned | Class (1) | |||||||
|
Name of Beneficial Owner
|
||||||||
|
5% Stockholders
|
||||||||
|
Philip N. Hudson
P.O. Box 160892 San Antonio, TX 78280-3092 (2) |
4,000,000 | 6.9 | % | |||||
|
|
||||||||
|
Westvaco Brand Security, Inc.
One High Ridge Park Stamford, CT 06905 (3) |
3,917,030 | 6.8 | % | |||||
|
|
||||||||
|
Ross. L Campbell
675 Lewis Lane Ambler, PA 19002 (4) |
3,264,457 | 5.6 | % | |||||
|
|
||||||||
|
Directors and Officers
|
||||||||
|
Michael A Feinstein, M.D. (5)
|
3,231,881 | 5.5 | % | |||||
|
William P. Curtis, Jr. (6)
|
472,428 | * | ||||||
|
Herman M. Gerwitz (7)
|
503,500 | * | ||||||
|
Richard Levitt (8)
|
450,000 | * | ||||||
|
Philip B. White (9)
|
371,745 | * | ||||||
|
All Executive Officers and Directors as a Group (6 individuals) (10)
|
5,080,154 | 8.8 | % | |||||
| * |
Less than 1.0%.
|
|
| (1) |
Where the Number of Shares Beneficially Owned (reported in the preceding column)
includes shares which may be purchased upon the exercise of outstanding stock options and
warrants which are or within sixty days will become exercisable (presently exercisable
options) the percentage of class reported in this column has been calculated assuming the
exercise of such presently exercisable options.
|
|
| (2) |
As reflected in a Schedule 13D dated August 11, 2008 filed on behalf of Philip N.
Hudson and subsequent open market purchases as reported to the Company by Mr. Hudson.
|
|
| (3) |
As reflected in a Schedule 13D dated March 14, 2001 filed on behalf of Westvaco Brand
Security, Inc.
|
|
| (4) |
As reflected in a Schedule 13D dated April 4, 2005 filed on behalf of Ross L. Campbell.
|
|
| (5) |
Includes 656,000 shares held by a pension plan of which Dr. Feinstein is a trustee,
100,000 shares held in an IRA and 200,000 presently exercisable stock options.
|
|
| (6) |
Includes, subject to Board of Directors approval, warrants to purchase 15,000 shares of
Common Stock.
|
|
| (7) |
Includes 50,000 shares held by a trust on behalf of a child of Mr. Gerwitz, 72,500
shares held by a child of Mr. Gerwitz, 6,000 shares held in an IRA, 200,000 presently
exercisable stock options and
presently exercisable warrants to purchase 7,500 shares of Common Stock.
|
21
| (8) |
Includes 200,000 presently exercisable stock options.
|
|
| (9) |
Includes 100,000 presently exercisable stock options and 50,000 presently exercisable
stock options held by Mr. Whites wife.
|
|
| (10) |
Includes 800,000 presently exercisable stock options, presently exercisable warrants to
purchase 7,500 shares of Common Stock and, subject to Board of Directors approval, warrants
to purchase 15,000 shares of Common Stock.
|
| Number of securities | ||||||||||||
| remaining available for | ||||||||||||
| Weighted-average | future issuance under | |||||||||||
| Number of securities to | exercise price of | equity compensation | ||||||||||
| be issued upon exercise | outstanding options, | plans (excluding | ||||||||||
| of outstanding options, | warrants and rights | securities reflected in | ||||||||||
| Plan Category | warrants and rights | compensation plans | column (a)) | |||||||||
| (a) | (b) | (c) | ||||||||||
|
Equity Compensation
plans approved by
security holders
|
300,000 | $ | .22 | -0- | ||||||||
|
Equity Compensation
plans not approved by
security holders (1)
|
645,000 | $ | .32 | -0- | ||||||||
|
Warrants issued in connection with
short-term loans (2)
|
97,500 | $ | .15 | -0- | ||||||||
|
|
||||||||||||
|
Total
|
1,042,500 | $ | .28 | -0- | ||||||||
|
|
||||||||||||
| (1) |
Registrants 1999 Stock Option Plan was adopted by the Registrants Board of Directors
in February 1999. The Plan provided for the grant of incentive or non-qualified options to
purchase up to 2,000,000 shares of common restricted stock of the Registrant to employees,
directors, consultants and advisors. The Plan was administered by the Board of Directors or
a committee of not less than two board members appointed by the board. The Plan terminated
in February 2009 on the tenth anniversary of its adoption.
|
|
| (2) |
Warrants issued in connection with the receipt of short term-notes totaling $57,000 in
2006 and $50,500 in 2010 were approved by the Board of Directors. In 2008, 10,000 warrants
were exercised. The warrants expire five years from the date of issuance.
|
| ITEM 13. |
CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE
|
22
| ITEM 14. |
PRINCIPAL ACCOUNTING FEES AND SERVICES
|
| ITEM 15. |
EXHIBITS, FINANCIAL STATEMENT SCHEDULES
|
23
|
NOCOPI TECHNOLOGIES, INC.
|
||||
| Date: March 31, 2011 | By: | /s/ Michael A. Feinstein, M.D. | ||
| Michael A. Feinstein, M.D. | ||||
| Title: |
Chairman of the Board, President and
Chief Executive Officer |
|||
| Signature | Title | Date | ||
|
|
||||
|
/s/ Michael A. Feinstein, M.D.
|
Chairman of the Board, President and | March 31, 2011 | ||
|
Michael A. Feinstein, M.D.
|
Chief Executive Officer
(Principal Executive Officer) |
|||
|
|
||||
|
/s/ Rudolph A. Lutterschmidt
|
Vice President, Chief Financial Officer and | March 31, 2011 | ||
|
Rudolph A. Lutterschmidt
|
Chief Accounting Officer
(Principal Financial and Accounting Officer) |
|||
|
|
||||
|
/s/ William P. Curtis, Jr.
|
Director | March 31, 2011 | ||
|
William P. Curtis, Jr.
|
||||
|
|
||||
|
/s/ Herman M. Gerwitz
|
Director | March 31, 2011 | ||
|
Herman M. Gerwitz
|
||||
|
|
||||
|
/s/ Richard Levitt
|
Director | March 31, 2011 | ||
|
Richard Levitt
|
||||
|
|
||||
|
/s/ Philip B. White
|
Director | March 31, 2011 | ||
|
Philip B. White
|
24
| F-2 | ||||
|
|
||||
| F-3 | ||||
|
|
||||
| F-4 | ||||
|
|
||||
| F-5 | ||||
|
|
||||
| F-6 | ||||
|
|
||||
| F-7 to F-15 | ||||
F-1
|
/s/ MORISON COGEN, LLP
|
||
|
|
||
|
Bala Cynwyd, Pennsylvania
|
||
|
March 31, 2011
|
F-2
| December 31 | ||||||||
| 2010 | 2009 | |||||||
|
Assets
|
||||||||
|
Current assets
|
||||||||
|
Cash
|
$ | 10,600 | $ | 37,200 | ||||
|
Accounts receivable less $5,000 allowance for doubtful
accounts
|
171,100 | 140,400 | ||||||
|
Inventory
|
34,800 | 66,100 | ||||||
|
Prepaid and other
|
37,200 | 35,200 | ||||||
|
|
||||||||
|
Total current assets
|
253,700 | 278,900 | ||||||
|
|
||||||||
|
Fixed assets
|
||||||||
|
Leasehold improvements
|
72,500 | 72,500 | ||||||
|
Furniture, fixtures and equipment
|
184,500 | 184,900 | ||||||
|
|
||||||||
|
|
257,000 | 257,400 | ||||||
|
Less: accumulated depreciation and amortization
|
247,400 | 242,200 | ||||||
|
|
||||||||
|
|
9,600 | 15,200 | ||||||
|
|
||||||||
|
Total assets
|
$ | 263,300 | $ | 294,100 | ||||
|
|
||||||||
|
|
||||||||
|
Liabilities and Stockholders Deficiency
|
||||||||
|
|
||||||||
|
Current liabilities
|
||||||||
|
Line of credit
|
$ | 93,800 | $ | 100,000 | ||||
|
Demand loans
|
50,500 | | ||||||
|
Accounts payable
|
263,400 | 268,400 | ||||||
|
Accrued expenses
|
142,500 | 106,900 | ||||||
|
Deferred revenue
|
46,500 | 13,900 | ||||||
|
|
||||||||
|
Total current liabilities
|
596,700 | 489,200 | ||||||
|
|
||||||||
|
Commitments and contingencies
|
||||||||
|
|
||||||||
|
Stockholders deficiency
|
||||||||
|
Series A preferred stock, $1.00 par value
|
||||||||
|
Authorized 300,000 shares
|
||||||||
|
Issued and outstanding none
|
||||||||
|
Common stock, $.01 par value
|
||||||||
|
Authorized 75,000,000 shares
|
||||||||
|
Issued and outstanding
|
||||||||
|
2010 57,852,041 shares; 2009 54,972,296 shares
|
578,500 | 549,700 | ||||||
|
Paid-in capital
|
12,365,400 | 12,287,400 | ||||||
|
Accumulated deficit
|
(13,277,300 | ) | (13,032,200 | ) | ||||
|
|
||||||||
|
|
(333,400 | ) | (195,100 | ) | ||||
|
|
||||||||
|
Total liabilities and stockholders deficiency
|
$ | 263,300 | $ | 294,100 | ||||
|
|
||||||||
| * |
The accompanying notes are an integral part of these financial statements.
|
F-3
| Years ended December 31 | ||||||||
| 2010 | 2009 | |||||||
|
Revenues
|
||||||||
|
Licenses, royalties and fees
|
$ | 373,700 | $ | 377,900 | ||||
|
Product and other sales
|
285,000 | 290,200 | ||||||
|
|
||||||||
|
|
658,700 | 668,100 | ||||||
|
|
||||||||
|
|
||||||||
|
Cost of revenues
|
||||||||
|
Licenses, royalties and fees
|
67,500 | 86,400 | ||||||
|
Product and other sales
|
208,000 | 239,200 | ||||||
|
|
||||||||
|
|
275,500 | 325,600 | ||||||
|
|
||||||||
|
Gross profit
|
383,200 | 342,500 | ||||||
|
|
||||||||
|
|
||||||||
|
Operating expenses
|
||||||||
|
Research and development
|
132,300 | 165,900 | ||||||
|
Sales and marketing
|
152,800 | 259,200 | ||||||
|
General and administrative
|
332,500 | 372,400 | ||||||
|
|
||||||||
|
|
617,600 | 797,500 | ||||||
|
|
||||||||
|
Net loss from operations
|
(234,400 | ) | (455,000 | ) | ||||
|
|
||||||||
|
|
||||||||
|
Other income (expenses)
|
||||||||
|
Reversal of accounts payable
|
| 69,100 | ||||||
|
Interest expense, bank charges and financing cost
|
(10,700 | ) | (3,500 | ) | ||||
|
|
||||||||
|
|
(10,700 | ) | 65,600 | |||||
|
|
||||||||
|
Net loss
|
$ | (245,100 | ) | $ | (389,400 | ) | ||
|
|
||||||||
|
|
||||||||
|
Basic and diluted net loss per common share
|
$ | (.00 | ) | $ | (.01 | ) | ||
|
|
||||||||
|
Basic and diluted weighted average common shares
outstanding
|
56,041,549 | 53,124,118 | ||||||
| * |
The accompanying notes are an integral part of these financial statements.
|
F-4
| Common stock | Paid-in | Accumulated | ||||||||||||||||||
| Shares | Amount | Capital | Deficit | Total | ||||||||||||||||
|
|
||||||||||||||||||||
|
Balance January 1, 2009
|
52,285,837 | $ | 522,900 | $ | 12,132,300 | $ | (12,642,800 | ) | $ | 12,400 | ||||||||||
|
|
||||||||||||||||||||
|
Sales of common stock
|
2,686,459 | 26,800 | 135,200 | 162,000 | ||||||||||||||||
|
|
||||||||||||||||||||
|
Stock option compensation
|
19,900 | 19,900 | ||||||||||||||||||
|
|
||||||||||||||||||||
|
Net loss
|
(389,400 | ) | (389,400 | ) | ||||||||||||||||
|
|
||||||||||||||||||||
|
Balance December 31, 2009
|
54,972,296 | 549,700 | 12,287,400 | (13,032,200 | ) | (195,100 | ) | |||||||||||||
|
|
||||||||||||||||||||
|
Sales of common stock
|
2,879,745 | 28,800 | 72,800 | 101,600 | ||||||||||||||||
|
|
||||||||||||||||||||
|
Stock option compensation
|
3,000 | 3,000 | ||||||||||||||||||
|
|
||||||||||||||||||||
|
Fair value of warrants issued to demand loan
holders
|
2,200 | 2,200 | ||||||||||||||||||
|
|
||||||||||||||||||||
|
Net loss
|
(245,100 | ) | (245,100 | ) | ||||||||||||||||
|
|
||||||||||||||||||||
|
Balance December 31, 2010
|
57,852,041 | $ | 578,500 | $ | 12,365,400 | $ | (13,277,300 | ) | $ | (333,400 | ) | |||||||||
|
|
||||||||||||||||||||
| * |
The accompanying notes are an integral part of these financial statements.
|
F-5
| Years ended December 31 | ||||||||
| 2010 | 2009 | |||||||
|
Operating Activities
|
||||||||
|
Net loss
|
$ | (245,100 | ) | $ | (389,400 | ) | ||
|
Adjustments to reconcile net loss to cash
used in operating activities
|
||||||||
|
Depreciation and amortization
|
7,900 | 9,100 | ||||||
|
Compensation expense stock option grants
|
3,000 | 19,900 | ||||||
|
Financing cost warrant grants
|
2,200 | | ||||||
|
Reversal of accounts payable
|
| (69,100 | ) | |||||
|
|
||||||||
|
|
(232,000 | ) | (429,500 | ) | ||||
|
|
||||||||
|
|
||||||||
|
(Increase) decrease in assets
|
||||||||
|
Accounts receivable
|
(30,700 | ) | 26,700 | |||||
|
Inventory
|
31,300 | 31,100 | ||||||
|
Prepaid and other
|
(2,000 | ) | 700 | |||||
|
Increase in liabilities
|
||||||||
|
Accounts payable and accrued expenses
|
30,600 | 55,100 | ||||||
|
Deferred revenue
|
32,600 | 3,900 | ||||||
|
|
||||||||
|
|
61,800 | 117,500 | ||||||
|
|
||||||||
|
Net cash used in operating activities
|
(170,200 | ) | (312,000 | ) | ||||
|
|
||||||||
|
|
||||||||
|
Investing Activities
|
||||||||
|
Additions to fixed assets
|
(2,300 | ) | | |||||
|
|
||||||||
|
Net cash used in investing activities
|
(2,300 | ) | | |||||
|
|
||||||||
|
|
||||||||
|
Financing Activities
|
||||||||
|
Net borrowings (repayments) under line of credit
|
(6,200 | ) | 100,000 | |||||
|
Proceeds from demand loans
|
50,500 | | ||||||
|
Issuance of common stock
|
101,600 | 162,000 | ||||||
|
Net cash provided by financing activities
|
145,900 | 262,000 | ||||||
|
|
||||||||
|
Decrease in cash
|
(26,600 | ) | (50,000 | ) | ||||
|
Cash
|
||||||||
|
Beginning of year
|
37,200 | 87,200 | ||||||
|
|
||||||||
|
End of year
|
$ | 10,600 | $ | 37,200 | ||||
|
|
||||||||
|
|
||||||||
|
Supplemental Disclosure of Cash Flow Information
|
||||||||
|
Cash paid for interest
|
$ | 3,800 | $ | 2,100 | ||||
|
|
||||||||
|
Supplemental Disclosure of Non Cash Investing Activities
|
||||||||
|
Write-off of fully depreciated furniture, fixtures and equipment
|
||||||||
|
Furniture, fixtures and equipment
|
$ | 2,700 | | |||||
|
Accumulated depreciation
|
$ | 2,700 | | |||||
| * |
The accompanying notes are an integral part of these financial statements.
|
F-6
| 1. |
Organization of the Company
|
|
Nocopi Technologies, Inc. (the Company) is organized under the laws of the State of Maryland.
Its main business activities are the development and distribution of document security products
and the licensing of its patented reactive ink technologies for the Entertainment and Toy and
the Document and Product Authentication markets in the United States and foreign countries. The
Company operates in one principal industry segment.
|
| 2. |
Significant Accounting Policies
|
|
Financial Statement Presentation
Amounts included in the accompanying financial statements
have been rounded to the nearest hundred, except for number of shares and per share
information.
|
|
Estimates
The preparation of the financial statements in conformity with Accounting
Principles Generally Accepted in the United States requires management to make estimates and
assumptions that affect the reported amounts of assets and liabilities and disclosure of
contingent liabilities at the dates of financial statements and the reported amounts of
revenues and expenses during the reported periods. Actual results could differ from those
estimates.
|
|
Cash
consists of demand deposits with a major U.S. bank.
|
|
Accounts receivable
As amounts become uncollectible, they will be charged to an allowance or
operations in the period when a determination of uncollectibility is made. Any estimates of
potentially uncollectible customer accounts receivable will be made based on an analysis of
individual customer and historical write-off experience. The Companys analysis includes the
age of the receivable account, creditworthiness and general economic conditions.
|
|
Inventory
consists primarily of ink components and paper and is stated at the lower of cost
(determined by the first-in, first-out method) or market.
|
|
Fixed assets
are carried at cost less accumulated depreciation and amortization. Furniture,
fixtures and equipment are generally depreciated on the straight-line method over their
estimated service lives. Leasehold improvements are amortized on a straight-line basis over the
shorter of five years or the term of the lease. Major renovations and betterments are
capitalized. Maintenance, repairs and minor items are expensed as incurred. Upon disposal,
assets and related depreciation are removed from the accounts and the net amount, less proceeds
from disposal, is charged or credited to income. In 2010, the Company wrote off approximately
$2,700 of fully depreciated furniture, fixtures and equipment that had been disposed of during
the year, along with an equal amount of accumulated depreciation. There was no effect on the
Companys results of operations.
|
|
Patent costs
are charged to expense as incurred due to the uncertainty of their recoverability
as a result of the Companys adverse liquidity situation.
|
F-7
|
Revenues
In accordance with Financial Accounting Standards Board Accounting Standards
Codification (FASB ASC) 605, Revenue Recognition
,
the Company recognizes revenue when (i)
persuasive evidence of a customer or distributor arrangement exists or acceptance occurs, (ii)
a retailer, distributor or wholesaler receives the goods, (iii) the price is fixed or
determinable, and (iv) collectability of the sales revenue is reasonably assured. Subject to
these criteria, the Company will generally recognize revenue upon shipment of product. Revenue
from license fees and royalties will be recognized as earned over the license term.
|
|
Income taxes
Deferred income taxes are provided for all temporary differences and net
operating loss and tax credit carryforwards. Deferred tax assets are reduced by a valuation
allowance when, in the opinion of management, it is more likely than not that some portion or
all of the deferred tax assets will not be realized.
|
|
Fair value
The carrying amounts reflected in the balance sheets for cash, receivables,
accounts payable and accrued expenses approximate fair value due to the short maturities of
these instruments. The carrying amount of the line of credit approximates fair value since the
interest rate associated with the debt approximates the current market interest rates.
|
|
Earnings (loss) per share
The Company follows FASB ASC 260, Earnings Per Share, resulting
in the presentation of basic and diluted earnings per share. Because the Company reported a net
loss for the years ended December 31, 2010 and December 31, 2009, common stock equivalents,
consisting of stock options and warrants, were anti-dilutive for those periods.
|
|
Comprehensive income (loss)
The Company follows FASB ASC 220 in reporting comprehensive
income. Comprehensive income is a more inclusive financial reporting methodology that includes
disclosure of certain financial information that historically has not been recognized in the
calculation of net income. Since the Company has no items of other comprehensive income,
comprehensive income (loss) is equal to net income (loss).
|
|
Recoverability of Long-Lived Assets
|
|
The Company follows FASB ASC 360-35, Impairment or Disposal of Long-Lived Assets. The
Statement requires that long-lived assets and certain identifiable intangibles be reviewed for
impairment whenever events or changes in circumstances indicate that the carrying amount of the
asset may not be recoverable. The Company is not aware of any events or circumstances which
indicate the existence of an impairment which would be material to the Companys annual
financial statements.
|
|
Recently Adopted Accounting Pronouncements
|
|
As of December 31, 2010 and for the year then ended, there were no recently adopted accounting
pronouncements that had a material effect on the Companys financial statements.
|
|
As of December 31, 2010, the FASB has issued Accounting Standards Updates (ASU) through No.
2010-29. None of the ASUs have had an impact on the Companys financial statements.
|
|
Recently Issued Accounting Pronouncements Not Yet Adopted
|
|
As of December 31, 2010, there are no recently issued accounting standards not yet adopted
which would have a material effect on the Companys financial statements.
|
F-8
| 3. |
Going Concern
|
|
Since its inception, with the exception of the year ended December 31, 2007 during which it
generated net income of $386,000, the Company has incurred significant losses and, as of
December 31, 2010, had accumulated losses of $13,277,300. For the years ended December 31, 2010
and December 31, 2009, the Companys had a net loss from operations of $234,400 and $455,000,
respectively. The Company had negative working capital of $343,000 at December 31, 2010 and
$210,300 at December 31, 2009. Due in part to the recession which has and is continuing to
negatively impact the countrys economy, the Company, which is substantially dependent on its
licensees to generate licensing revenues, may incur further operating losses and experience
negative cash flow in the future. Achieving profitability and positive cash flow depends on the
Companys ability to generate and sustain significant increases in revenues and gross profits
from its traditional business. There can be no assurances that the Company will be able to
generate sufficient revenues and gross profits to return to and sustain profitability and
positive cash flow in the future.
|
|
During 2010, the Company received unsecured loans totaling $50,500 from four individuals, of
which $7,500 was lent by Herman M. Gerwitz, a Director. In 2010, the Company raised $101,600 in
a private placement exempt from registration under section 4(2) of the Securities Act of 1933,
as amended, whereby 2,668,333 shares of the Companys common stock were sold to five
non-affiliated individual investors and 211,412 shares of the Companys common stock were sold
to two Directors of the Company. During 2009, the Company raised $162,000 in this private
placement whereby 2,426,042 shares of the Companys common stock were sold to six
non-affiliated individual investors and 260,417 were sold to a Director of the Company. Receipt
of funds from these investors and from the demand loan holders, along with borrowings during
2009 under its line of credit with a bank, has permitted the Company to continue in operation
to the current date. During 2009, the Company borrowed the entire $100,000 under the line of
credit, obtained in 2008, to fund its operating activities. In August 2010, the Company
accepted an offer by the bank to repay the outstanding loan balance in forty-eight equal
monthly installments, plus interest, beginning in October 2010. Management of the Company
believes that it will need additional capital in the immediate future both to fund investments
needed to increase its operating revenues to levels that will sustain its operations and to
fund operating deficits that it anticipates will continue until revenue increases from
traditional and new product lines can be realized. There can be no assurances that the Company
will be successful in obtaining sufficient additional capital, or if it does, that the
additional capital will enable the Company to impact its revenues so as to have a material
positive effect on the Companys operations and cash flow. The Company believes that without
additional capital, whether in the form of debt, equity or both, it may be forced to cease
operations in the near future.
|
|
The Companys independent registered public accountants have included a going concern
explanatory paragraph in their audit report accompanying the 2010 financial statements. The
paragraph states that the Companys recurring losses from operations raise substantial doubt
about the Companys ability to continue as a going concern and cautions that the financial
statements do not include any adjustments that might result from the outcome of this
uncertainty.
|
F-9
| 4. |
Concentration of Credit Risk
|
|
Certain financial instruments potentially subject the Company to concentrations of credit
risk. These financial instruments consist primarily of cash and accounts receivables. At
December 31, 2010, the Company did not have deposits with a financial institution that exceed
the FDIC deposit insurance coverage of $250,000. There is a concentration of credit risk with
respect to accounts receivable due to the number of major customers.
|
| 5. |
Demand Loans
|
|
In March 2010, the Company received unsecured loans totaling $40,500 from three individuals of
which $7,500 was lent by Herman M. Gerwitz, a Director. The loans bear interest at 8% and are
payable on demand. The loans were used to finance the Companys working capital requirements.
Additionally, the Company granted warrants, approved by the Companys Board of Directors, to
purchase 40,500 shares of common stock of the Company at $.0703 per share to these three
individuals. The warrants expire in five years. A financing cost of approximately $1,800
representing the fair value of the warrants was charged to income in the first quarter of
2010. The fair value of the warrants was determined using the Black-Scholes pricing model with
the following assumptions: expected life-5 years; interest rate-2.65%; volatility-77% and
dividend yield-0. In May 2010, the Company received an unsecured loan of $10,000 from an
individual. The loan bears interest at 8% and is payable on demand. The loan was used to
finance the Companys working capital requirements. Additionally, the Company granted
warrants, approved by the Companys Board of Directors, to purchase 10,000 shares of common
stock of the Company at $.06 per share to this individual. The warrants expire in five years.
A financing cost of approximately $400 representing the fair value of the warrants was charged
to income in the second quarter of 2010. The fair value of the warrants was determined using
the Black-Scholes pricing model with the following assumptions: expected life-5 years;
interest rate-2.11%; volatility-78% and dividend yield-0. The acceptance of these unsecured
loans constitutes a violation of certain covenants under the Companys line of credit which
gives the lender certain rights including requiring the Company to repay the entire
outstanding loan balance which was $93,750 at December 31, 2010. Such a requirement by the
bank could have a material adverse effect on the Companys financial condition. Management of
the Company intends to cure this violation.
|
| 6. |
Line of Credit
|
|
In 2008, the Company negotiated a $100,000 revolving line of credit with a bank to provide a
source of working capital. The line of credit is secured by all the assets of the Company and
bears interest at the banks prime rate plus 0.5%. At December 31, 2010, the interest rate
applicable to the Companys line of credit was 3.75%. During the year ended December 31, 2009,
the Company borrowed the entire $100,000 available under the line of credit. Until the third
quarter of 2010, the Company had been required to pay interest only on borrowings under the
line of credit. During the third quarter of 2010, the Company was notified by the bank that the
line of credit was not being renewed and was offered repayment terms, which the Company
accepted, to repay the outstanding loan balance in forty-eight equal monthly installments of
$2,083, plus interest at the banks prime rate plus 0.5%, beginning in October 2010. At
December 31, 2010, the line of credit balance was $93,750. Future installment payments under
this repayment arrangement are: $25,000 2011; $25,000 2012; $25,000 2013 and $18,750
2014.
|
F-10
| 7. |
Stockholders Deficiency
|
|
During 2010, the Company sold 2,668,333 shares of its common stock to six non-affiliated
individuals, 148,912 shares of its common stock to Philip B. White, a Director, and 62,500
shares of its common stock to Herman M. Gerwitz, a Director, for a total of $101,600 pursuant
to a private placement. During 2009, the Company sold 2,426,042 shares of its common stock to
six non-affiliated individual investors and 260,417 shares to William P. Curtis, Jr., a
Director, for a total of $162,000 pursuant to a private placement.
|
| 8. |
Other Income (Expenses)
|
|
Other income (expenses) included, for the year ended December 31, 2009, a benefit from the
reversal of $69,100 of accounts payable by the Company related to invoices the Company had
received from 2001 through 2003 for consulting services provided by a third party. The
Company, with advice of legal counsel, determined that it was no longer legally required
to pay these invoices as the statute of limitations within which the consultant had to
bring a claim had expired.
|
| 9. |
Income Taxes
|
|
There is no income tax benefit for the years ended December 31, 2010 and December 31, 2009 due
to the availability of net operating loss carryforwards (NOLs) for which the Company had
previously established a 100% valuation allowance for deferred tax assets due to the
uncertainty of their recoverability. At December 31, 2010 and December 31, 2009, the Company
had NOLs approximating $6,104,000 and $7,194,000, respectively. The operating losses at
December 31, 2010 are available to offset future taxable income; however, if not utilized, they
expire in varying amounts through the year 2030. As a result of the sale of the Companys
common stock in an equity offering in late 1997 and the issuance of additional shares, the
amount of the NOLs may be limited. Additionally, the utilization of these NOLs, if available,
to reduce the future income taxes will depend on the generation of sufficient taxable income
prior to their expiration. There were no material temporary differences for the years ended
December 31, 2010 and December 31, 2009. The Company has established a 100% valuation allowance
of approximately $2,502,000 and $2,949,000 at December 31, 2010 and December 31, 2009,
respectively, for the deferred tax assets due to the uncertainty of their realization.
|
|
The Company has adopted the provisions of FASB ASC 740-10-50-15, Unrecognized Tax Benefit
Related Disclosures. There were no unrecognized tax benefits as of the date of adoption and no
unrecognized tax benefits at December 31, 2010. There was no change in unrecognized tax
benefits during the year ended December 31, 2010 and there was no accrual for uncertain tax
positions as of December 31, 2010.
|
|
There were no interest and penalties recognized in the statement of operations and in the
balance sheet. Tax years from 2007 through 2010 remain subject to examination by U.S. federal
and state tax jurisdictions.
|
F-11
| 10. |
Commitments and Contingencies
|
|
The Company conducts its operations in leased facilities and leases equipment under
non-cancelable operating leases expiring at various dates to 2013.
|
|
Future minimum lease payments under non-cancelable operating leases with initial or remaining
terms of one year or more at December 31, 2010 are: $43,200 2011; $44,400 2012 and
$11,400 2013.
|
|
Total rental expense under operating leases was $42,400 in both 2010 and 2009.
|
|
The Company has an employment agreement, expiring in May 2012, with Michael A. Feinstein, M.D.,
its Chairman of the Board and Chief Executive Officer. The employment agreement contains
one-year renewal provisions that become effective after the original term. Dr. Feinstein
receives base compensation of $85,000 per year plus a performance bonus determined by the
Companys Board of Directors. Future minimum compensation payments under this employment
agreement are: $85,000 2011; and $35,400 2012.
|
|
From time to time, the Company may be subject to legal proceedings and claims that arise in the
ordinary course of its business.
|
| 11. |
Stock Options, Warrants and
401(k)
Savings Plan
|
|
The Company follows FASB ASC 718,
Share Based Payment,
which requires that the cost resulting
from all share-based payment transactions be recognized in the Companys financial statements.
FASB ASC 718 requires all share-based payments to employees, including grants of employee stock
options, to be recognized in the statement of operations based on their fair values.
|
|
The 1996 and 1999 Stock Option Plans provided for the granting of up to 2,700,000 incentive and
non-qualified stock options to employees, non-employee directors, consultants and advisors to
the Company. In the case of options designated as incentive stock options, the exercise price
of the options granted must be not less than the fair market value of such shares on the date
of grant. Non-qualified stock options may be granted at any amount established by the Stock
Option Committee or, in the case of Discounted Options issued to non-employee directors in lieu
of any portion of an Annual Retainer, in accordance with a formula designated in the Plan. The
1996 Stock Option Plan terminated in June 2006 and no further stock options can be granted
under the plan; however, options granted before June 2006 may be exercised through their
expiration date. The 1999 Stock Option Plan terminated in February 2009 and no further stock
options can be granted under the plan; however, options granted before the termination date may
be exercised through their expiration date.
|
|
The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value
of an award.
|
F-12
| Exercise | Weighted | |||||||||||
| Number of | Price Range | Average | ||||||||||
| Shares | Per Share | Exercise Price | ||||||||||
|
Outstanding at December 31, 2008
|
2,250,000 | $.10 to $.45 | $ | .23 | ||||||||
|
Options granted
|
325,000 | .12 | .12 | |||||||||
|
Options canceled
|
1,250,000 | .10 to .45 | .19 | |||||||||
|
|
||||||||||||
|
Outstanding at December 31, 2009
|
1,325,000 | .10 to .45 | .24 | |||||||||
|
Options canceled
|
380,000 | .10 to .12 | .11 | |||||||||
|
|
||||||||||||
|
Outstanding at December 31, 2010
|
945,000 | $.12 to $.45 | $ | .29 | ||||||||
|
|
||||||||||||
| Exercise | Weighted | |||||||||||
| Option | Price Range | Average | ||||||||||
| Shares | Per Share | Exercise Price | ||||||||||
|
Exercisable options at year end:
|
||||||||||||
|
2010
|
945,000 | $.12 to $.45 | $ | .29 | ||||||||
|
Weighted average remaining contractual life (years)
|
1.91 | |||||||||||
|
Options available for future grant under all plans:
|
||||||||||||
|
2010
|
0 | |||||||||||
|
In February 2009, the Board of Directors of the Company, under the Companys 1999 Stock Option
Plan, granted options to acquire 200,000 shares of its common stock to five employees of the
Company, options to acquire 75,000 shares of its common stock to two consultants and options to
acquire 50,000 shares of its common stock to an officer of the Company at $.12 per share. The
options vested in February 2010 and expire after five years. In accordance with the fair value
method as described in accounting requirements of FASB ASC 718, compensation expense of
approximately $22,900 was recognized over the vesting period of the options through February
2010 to account for the cost of services received by the Company in exchange for the grant of
stock options. The fair value was determined using the Black-Scholes pricing model with the
following assumptions: expected life-5 years; interest rate-1.81%; volatility-70% and dividend
yield-0. During the years ended December 31, 2010 and December 31, 2009, compensation expense
of approximately $3,000 and $19,900, respectively, was recognized. There was no unrecognized
portion of expense at December 31, 2010.
|
|
At December 31, 2010, the Company had 97,500 warrants to purchase common stock of the Company
outstanding at exercise prices ranging from $.06 to $.27 and expiring at various dates through
May 2015. The warrants were granted in conjunction with loans provided to the Company by five
individuals in 2006 and 2010.
|
F-13
|
A summary of outstanding warrants follows:
|
| Exercise | Weighted | |||||||||||
| Number of | Price Range | Average | ||||||||||
| Shares | Per Share | Exercise Price | ||||||||||
|
Outstanding at December 31, 2008 and 2009
|
47,000 | $.21 to $.27 | $ | .23 | ||||||||
|
Warrants granted
|
50,500 | .06 and .07 | .07 | |||||||||
|
Outstanding at December 31, 2010
|
97,500 | $.06 to $.27 | $ | .14 | ||||||||
| Exercise | Weighted | |||||||||||
| Price Range | Average | |||||||||||
| Shares | Per Share | Exercise Price | ||||||||||
|
Exercisable warrants at year end:
|
||||||||||||
|
2010
|
97,500 | $.06 to $.27 | $ | .14 | ||||||||
|
Weighted average remaining contractual life (years)
|
2.52 | |||||||||||
|
At December 31, 2010, the Company has reserved 1,042,500 shares of common stock for
possible future issuance upon exercise of 945,000 stock options and 97,500 warrants.
|
|
The Company sponsors a 401(k) savings plan, covering substantially all employees, providing for
employee and employer contributions. Employer contributions are made at the discretion of the
Company. There were no contributions charged to expense during 2010 or 2009.
|
| 12. |
Major Customer and Geographic Information
|
|
The Companys revenues, expressed as a percentage of total revenues, from non-affiliated
customers that equaled 10% or more of the Companys total revenues were:
|
| Year ended December 31 | ||||||||
| 2010 | 2009 | |||||||
|
Customer A
|
30 | % | 35 | % | ||||
|
Customer B
|
25 | % | 19 | % | ||||
|
Customer C
|
9 | % | 21 | % | ||||
|
The Companys non-affiliate customers whose individual balances amounted to more than 10% of
the Companys net accounts receivable, expressed as a percentage of net accounts receivable,
were:
|
| December 31 | ||||||||
| 2010 | 2009 | |||||||
|
Customer A
|
75 | % | 59 | % | ||||
|
Customer B
|
16 | % | 19 | % | ||||
|
Customer C
|
| 13 | % | |||||
|
The Company performs ongoing credit evaluations of its customers and generally does not require
collateral. The Company also maintains allowances for potential credit losses. The loss of a
major customer could have a material adverse effect on the Companys business operations and
financial condition.
|
F-14
|
The Companys revenues by geographic region are as follows:
|
| Year ended December 31 | ||||||||
| 2010 | 2009 | |||||||
|
North America
|
$ | 569,800 | $ | 524,600 | ||||
|
Asia
|
61,900 | 142,600 | ||||||
|
South America
|
24,300 | | ||||||
|
Europe
|
2,700 | 900 | ||||||
|
|
||||||||
|
|
$ | 658,700 | $ | 668,100 | ||||
|
|
||||||||
| 13. |
Subsequent Events
|
|
In late January 2011, the Company received an unsecured loan of $15,000 from William P. Curtis,
Jr., a Director, and repaid the loan, along with interest at 8%, in early February 2011.
Additionally, subject to Board of Directors approval, the Company granted warrants to purchase
15,000 shares of common stock of the Company at $.06 per share to Mr. Curtis. The warrants
expire in five years. A financing cost of approximately $600 representing the fair value of the
warrants is being charged to income in the first quarter of 2011. The loan was used to finance
the Companys short-term working capital requirements.
|
F-15
| Exhibit | ||||
| Number | Description | |||
|
|
||||
| 3.1 |
Amended and Restated Articles of Incorporation (19)
|
|||
|
|
||||
| 3.2 |
Amended and Restated Bylaws (20)
|
|||
|
|
||||
| 4.1 |
Form of Certificate of Common Stock (14)
|
|||
|
|
||||
| 10.1 | |
Summary Plan Description for Nocopi Technologies, Inc. 401(k)
Profit Sharing Plan (1)
|
||
|
|
||||
| 10.2 | |
Nocopi Technologies, Inc. 1996 Stock Option Plan (2)
|
||
|
|
||||
| 10.3 | |
Nocopi Technologies, Inc. 1999 Stock Option Plan (3)
|
||
|
|
||||
| 10.4 | |
Amended Summary Plan Description for Nocopi Technologies, Inc. 401(k) Profit Sharing Plan (3)
|
||
|
|
||||
| 10.5 |
Director Indemnification Agreement (4)
|
|||
|
|
||||
| 10.6 |
Officer Indemnification Agreement (5)
|
|||
|
|
||||
| 10.7 |
Stock Purchase Agreement with Westvaco Brand Security, Inc. (6)
|
|||
|
|
||||
| 10.8 |
Registration Rights Agreement with Westvaco Brand Security, Inc. (7)
|
|||
|
|
||||
| 10.9 |
Subscription Agreement with Entrevest I Associates (8)
|
|||
|
|
||||
| 10.10 |
Lease Agreement dated March 19, 2003 relating to premises at 9 Portland Road, West Conshohocken, PA 19428 (9)
|
|||
|
|
||||
| 10.11 |
Settlement Agreement with Euro-Nocopi, S.A. (10)
|
|||
|
|
||||
| 10.12 |
Agreement of Terms with Entrevest I Associates (11)
|
|||
|
|
||||
| 10.13 |
Conversion Agreement (12)
|
|||
|
|
||||
| 10.14 |
Patent License Agreement with Giddy Up, LLC and Color Loco, LLC (15)
|
|||
|
|
||||
| 10.15 |
Addendum #1 to Patent License Agreement with Giddy Up, LLC and Color Loco, LLC (16)
|
|||
|
|
||||
| 10.16 |
Amendment dated July 18, 2007 to Lease Agreement dated March 19, 2003 relating
to premises at 9 Portland Road, West Conshohocken, PA 19428 (17)
|
|||
|
|
||||
| 10.17 | |
Employment Agreement with Michael A. Feinstein, M.D. (18)
|
||
|
|
||||
| 10.18 |
Business Loan Agreement, Promissory Note and Commercial Security Agreement
dated August 19, 2008 between the Company and Sovereign Bank (21)
|
|||
|
|
||||
| 10.19 | |
Amended Summary Plan Description for Nocopi Technologies, Inc. 401(k) Profit Sharing
Plan (22)
|
||
|
|
||||
| 10.20 |
Patent License Agreement with Elmers Products, Inc. (23)
|
|||
| Exhibit | ||||
| Number | Description | |||
|
|
||||
| 14.1 |
Code of Ethics (13)
|
|||
|
|
||||
| 31.1 | * |
Certification of Chief Financial Officer required by Rule 13a-14(a)
|
||
|
|
||||
| 31.2 | * |
Certification of Chief Executive Officer required by Rule 13a-14(a)
|
||
|
|
||||
| 32.1 | * |
Certifications of Chief Executive Officer and Chief Financial Officer Pursuant
to 18 U.S.C. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act
of 2002
|
||
| * |
Exhibit filed with this Report.
|
|
| |
Compensation plans and arrangements for executives and others.
|
|
| (1) |
Incorporated by reference to Registrants Annual Report on Form 10-K for the Year Ended
December 31, 1993
|
|
| (2) |
Incorporated by reference to Registrants Annual Report on Form 10-K for the Year Ended
December 31, 1996
|
|
| (3) |
Incorporated by reference to Registrants Annual Report on Form 10-KSB for the Year Ended
December 31, 1998
|
|
| (4) |
Incorporated by reference to Exhibit 10.19 of the Registrants Quarterly Report on Form
10-QSB for the Three Months Ended September 30, 1999 filed on November 15, 1999
|
|
| (5) |
Incorporated by reference to Exhibit 10.20 of the Registrants Quarterly Report on Form
10-QSB for the Three Months Ended September 30, 1999 filed on November 15, 1999
|
|
| (6) |
Incorporated by reference to Exhibit 10.17 of the Registrants Annual Report on Form 10-KSB
for the Year Ended December 31, 2000 filed on April 17, 2001
|
|
| (7) |
Incorporated by reference to Exhibit 10.18 of the Registrants Annual Report on Form 10-KSB
for the Year Ended December 31, 2000 filed on April 17, 2001
|
|
| (8) |
Incorporated by reference to Exhibit 10.18 of the Registrants Annual Report on Form 10-KSB
for the Year Ended December 31, 2002 filed on April 14, 2003
|
|
| (9) |
Incorporated by reference to Exhibit 10.19 of the Registrants Annual Report on Form 10-KSB
for the Year Ended December 31, 2002 filed on April 14, 2003
|
|
| (10) |
Incorporated by reference to Exhibit 10.17 of the Registrants Annual Report on Form 10-KSB
for the Year Ended December 31, 2003 filed on April 14, 2004
|
|
| (11) |
Incorporated by reference Exhibit 10.1 of the Registrants Current Report on Form 8-K filed
on September 16, 2004
|
|
| (12) |
Incorporated by reference to Exhibit 10.2 of the Registrants Quarterly Report on Form 10-QSB
for the Three Months Ended September 30, 2004 filed on November 15, 2004
|
|
| (13) |
Incorporated by reference to Exhibit 14.1 of the Registrants Annual Report on Form 10-KSB
for the Year Ended December 31, 2004 filed on March 31, 2005
|
|
| (14) |
Incorporated by reference to Exhibit 4.1 of the Registrants Annual Report on Form 10-KSB for
the Year Ended December 31, 2005 filed on April 7, 2006
|
|
| (15) |
Incorporated by reference to Exhibit 10.14 of the Registrants Annual Report on Form 10-KSB
for the Year Ended December 31, 2006 filed on April 16, 2007
|
|
| (16) |
Incorporated by reference to Exhibit 10.15 of the Registrants Annual Report on Form 10-KSB
for the Year Ended December 31, 2006 filed on April 16, 2007
|
| (17) |
Incorporated by reference to Exhibit 10.16 of the Registrants Quarterly Report on Form
10-QSB for the Three Months Ended September 30, 2007 filed on November 14, 2007
|
|
| (18) |
Incorporated by reference to Exhibit 10.17 of the Registrants Quarterly Report on Form 10-Q
for the Three Months Ended June 30, 2008 filed on August 14, 2008
|
|
| (19) |
Incorporated by reference to Exhibit 3.1 of the Registrants Quarterly Report on Form 10-Q
for the Three Months Ended September 30, 2008 filed on November 14, 2008
|
|
| (20) |
Incorporated by reference to Exhibit 3.2 of the Registrants Quarterly Report on Form 10-Q
for the Three Months Ended September 30, 2008 filed on November 14, 2008
|
|
| (21) |
Incorporated by reference to Exhibit 10.18 of the Registrants Quarterly Report on Form 10-Q
for the Three Months Ended September 30, 2008 filed on November 14, 2008
|
|
| (22) |
Incorporated by reference to Exhibit 10.19 of the Registrants Annual Report on Form 10-K for
the Year Ended December 31, 2009 filed on March 31, 2010
|
|
| (23) |
Incorporated by reference to Exhibit 10.20 of the Registrants Annual Report on Form 10-K for
the Year Ended December 31, 2009 filed on March 31, 2010
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|